New Issue: Credit Suisse sells $1.75 million accelerated barrier notes on basket

By Kiku Steinfeld

Chicago, April 26 – Credit Suisse AG, London Branch priced $1.75 million of 0% accelerated barrier notes due Sept. 30, 2025 linked to an equally-weighted basket of stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The basket consists of Amgen Inc., Gilead Sciences, Inc., Pfizer Inc. and Viatris, Inc.

If the basket finishes at or above its initial level, the payout at maturity will be par plus 2 times the return, capped at 72.25%.

If the basket declines but finishes at or above the 70% barrier level, the payout will be par.

Otherwise, investors will be fully exposed to the decline of the basket from its initial level.

The agent is Credit Suisse Securities (USA) LLC.

Issuer:	Credit Suisse AG, London Branch
Issue:	Accelerated barrier notes
Underlying basket:	Amgen Inc., Gilead Sciences, Inc., Pfizer Inc. and Viatris Inc.; equal weights
Amount:	$1.75 million
Maturity:	Sept. 30, 2025
Coupon:	0%
Price:	Par
Payout at maturity:	If the basket finishes at or above its initial level, par plus 2 times the return of the basket, capped at 72.25%; if the basket declines no farther than the barrier level, par; otherwise, investors will be fully exposed to the decline of the basket from its initial level
Initial basket level:	$212.27 for Amgen, $69.97 for Gilead, $43.04 for Pfizer, $13.70 for Viatris
Barrier level:	70% of initial level
Pricing date:	Sept. 29, 2021
Settlement date:	Sept. 30, 2021
Agent:	Credit Suisse Securities (USA) LLC
Fees:	2.85%
Cusip:	22552XWT6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.